LKB1 modulates lung cancer differentiation and metastasis
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Germline mutation in serine/threonine kinase 11 (STK11, also called LKB1) results in Peutz-Jeghers syndrome, characterized by intestinal hamartomas and increased incidence of epithelial cancers. Although uncommon in most sporadic cancers, inactivating somatic mutations of LKB1 have been reported in primary human lung adenocarcinomas and derivative cell lines. Here we used a somatically activatable mutant Kras-driven model of mouse lung cancer to compare the role of Lkb1 to other tumour suppressors in lung cancer. Although Kras mutation cooperated with loss of p53 or Ink4a/Arf (also known as Cdkn2a) in this system, the strongest cooperation was seen with homozygous inactivation of Lkb1. Lkb1-deficient tumours demonstrated shorter latency, an expanded histological spectrum (adeno-, squamous and large-cell carcinoma) and more frequent metastasis compared to tumours lacking p53 or Ink4a/Arf. Pulmonary tumorigenesis was also accelerated by hemizygous inactivation of Lkb1. Consistent with these findings, inactivation of LKB1 was found in 34% and 19% of 144 analysed human lung adenocarcinomas and squamous cell carcinomas, respectively. Expression profiling in human lung cancer cell lines and mouse lung tumours identified a variety of metastasis-promoting genes, such as NEDD9, VEGFC and CD24, as targets of LKB1 repression in lung cancer. These studies establish LKB1 as a critical barrier to pulmonary tumorigenesis, controlling initiation, differentiation and metastasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Beyond its role regulating metabolism via AMPK, LKB1 loss promotes tumorigenesis by reprogramming epigenetic states, facilitating lineage plasticity and promoting metastasis22,67–70.”
From LKB1 regulates JNK-dependent stress signaling and apoptotic dependency of KRAS-mutant lung cancers (2025) · cites this paper as [22]
In the citing paper
“Somatic deletion of Lkb1 is insufficient for initiation of lung carcinogenesis in mice as a singular event but dramatically accelerates KrasG12D-driven carcinogenesis and fosters early metastatic dissemination84.”
From Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy (2019) · cites this paper as [84]
In the citing paper
“In addition, loss of Lkb1 results in epigenetic reprogramming and an expanded tumor histological repertoire, with high incidence of squamous or adenosquamous carcinomas, in agreement with data supporting enrichment of LKB1 mutations in human adenosquamous NSCLC84–86.”
From Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy (2019) · cites this paper as [84]
In the citing paper
“Loss of p53 or expression of either dominant negative or dominant gain-of-function Trp53 mutants also co-operate with oncogenic Kras to induce LUADs with shortened latency and increased metastatic proclivity, although these tumors are less aggressive than those with Lkb1 loss69–71, 84.”
From Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy (2019) · cites this paper as [84]
Citations
Cites
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
Irizarry, R. A. (2003) · Biostatistics · doi:10.1093/biostatistics/4.2.249 · Cited by 10,603
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370 · cited 1×
“Only point mutation or deletion 8 of 80 (10) 4 of 42 (10) 1 of 22 (5) 13 of 144 (9) Only single-copy loss by MLPA 11 of 80 (14) 2 of 42 (5) 1 of 22 (5) 14 of 144 (10) Homozygous mutation or deletion 8{ of 80 (10) 2 of 42 (5) 0 of 22 (0) 10 of 144 (7) Total 27 of 80 (34) 8 of 42 (19) 2 of 22 (9) 37 of 144 (26)”
Bolstad, B. M., Irizarry, R. A., Åstrand, M., & Speed, T. P. (2003) · Bioinformatics · doi:10.1093/bioinformatics/19.2.185 · Cited by 8,266
Summaries of Affymetrix GeneChip probe level data
Irizarry, R. A. (2003) · Nucleic Acids Research · doi:10.1093/nar/gng015 · Cited by 4,887 · cited 1×
“Only point mutation or deletion 8 of 80 (10) 4 of 42 (10) 1 of 22 (5) 13 of 144 (9) Only single-copy loss by MLPA 11 of 80 (14) 2 of 42 (5) 1 of 22 (5) 14 of 144 (10) Homozygous mutation or deletion 8{ of 80 (10) 2 of 42 (5) 0 of 22 (0) 10 of 144 (7) Total 27 of 80 (34) 8 of 42 (19) 2 of 22 (9) 37 of 144 (26)”
Identification of Pancreatic Cancer Stem Cells
Li, C., Heidt, D. G., Dalerba, P., Burant, C. F., Zhang, L., Adsay, V., Wicha, M., Clarke, M. F., & Simeone, D. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2030 · Cited by 3,339
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras
Jackson, E. L., Willis, N., Mercer, K., Bronson, R. T., Crowley, D., Montoya, R., Jacks, T., & Tuveson, D. A. (2001) · Genes & Development · doi:10.1101/gad.943001 · Cited by 1,898 · cited 1×
“Only point mutation or deletion 8 of 80 (10) 4 of 42 (10) 1 of 22 (5) 13 of 144 (9) Only single-copy loss by MLPA 11 of 80 (14) 2 of 42 (5) 1 of 22 (5) 14 of 144 (10) Homozygous mutation or deletion 8{ of 80 (10) 2 of 42 (5) 0 of 22 (0) 10 of 144 (7) Total 27 of 80 (34) 8 of 42 (19) 2 of 22 (9) 37 of 144 (26)”
Self-citationRole of the INK4a Locus in Tumor Suppression and Cell Mortality
Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., & DePinho, R. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81079-x · Cited by 1,585
Molecular Definition of Breast Tumor Heterogeneity
Shipitsin, M., Campbell, L. L., Argani, P., Weremowicz, S., Bloushtain-Qimron, N., Yao, J., Nikolskaya, T., Serebryiskaya, T., Beroukhim, R., Hu, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.01.013 · Cited by 1,353
Somatic activation of the K-ras oncogene causes early onset lung cancer in mice
Johnson, L., Mercer, K., Greenbaum, D., Bronson, R. T., Crowley, D., Tuveson, D. A., & Jacks, T. (2001) · Nature · doi:10.1038/35074129 · Cited by 1,179 · cited 1×
“Only point mutation or deletion 8 of 80 (10) 4 of 42 (10) 1 of 22 (5) 13 of 144 (9) Only single-copy loss by MLPA 11 of 80 (14) 2 of 42 (5) 1 of 22 (5) 14 of 144 (10) Homozygous mutation or deletion 8{ of 80 (10) 2 of 42 (5) 0 of 22 (0) 10 of 144 (7) Total 27 of 80 (34) 8 of 42 (19) 2 of 22 (9) 37 of 144 (26)”
Self-citationThe LKB1 tumor suppressor negatively regulates mTOR signaling
Shaw, R. J., Bardeesy, N., Manning, B. D., Lopez, L., Kosmatka, M., DePinho, R. A., & Cantley, L. C. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.007 · Cited by 1,077
Self-citation
Cited by
Items 701–800 of 1,000
Liu, Z., Li, S., Zeng, J., Zhou, X., Li, H., Liu, X., Li, F., Jiang, B., Zhao, M., & Ma, T. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118068 · Cited by 12
Borzi, C., Galli, G., Ganzinelli, M., Signorelli, D., Vernieri, C., Garassino, M. C., Sozzi, G., & Moro, M. (2020) · Pharmaceuticals · doi:10.3390/ph13110385 · Cited by 15
“Indeed, in a conditionally activatable Lox-Stop-Lox KrasG12D mouse model [58], loss of LKB1 function resulted in faster tumor development, expanded histological lung cancer spectrum (adeno-, squamous, and large-cell carcinoma) and higher metastasis frequency compared to mice lacking other oncosuppressor genes like p53…”
BackgroundXu, J., Guo, H., Xing, Z., Zhang, W., He, J., Cheng, J., & Cai, R. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/6240125 · Cited by 13
LKB1 inhibits proliferation, metastasis and angiogenesis of thyroid cancer by upregulating SIK1
Kou, B., Wang, X., Sun, X.-P., Qi, Q., Yang, M. J., Yun, Y.-N., Zhou, J.-S., & Liu, W. (2022) · Journal of Cancer · doi:10.7150/jca.72021 · Cited by 12
“Studies showed that LKB1 could modulate lung cancer differentiation and metastasis [7].”
BackgroundLKB1 signaling in advancing cell differentiation
Udd, L., & Mäkelä, T. P. (2011) · Familial Cancer · doi:10.1007/s10689-011-9441-2 · Cited by 12
Lahtela, J., Pradhan, B., Närhi, K. M., Hemmes, A., Särkioja, M., Kovanen, P. E., Brown, A. M., & Verschuren, E. W. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.019257 · Cited by 14
Aberrant NRP-1 expression serves as predicator of metastatic endometrial and lung cancers
Okon, I. S., Ye, D., Coughlan, K. A., Wang, Q., Song, P., Benbrook, D. M., & Zou, M. (2015) · Oncotarget · doi:10.18632/oncotarget.6699 · Cited by 12
“This observation is in agreement with recent reports that describe NEDD9 as a target of LKB1 repression in lung cancer [32, 37].”
ResultNeidler, S., Kruspig, B., Hewit, K. D., Monteverde, T., Gyurászová, K., Braun, A., Clark, W. A., James, D. T., Hedley, A., Nieswandt, B., et al. (2019) · Cancers · doi:10.3390/cancers11050600 · Cited by 12
LKB1 regulates JNK-dependent stress signaling and apoptotic dependency of KRAS-mutant lung cancers
Li, C., Syed, M. U., Nimbalkar, A., Shen, Y., Vieira, M. D., Fraser, C., Inde, Z., Qin, X., Ouyang, J., Kreuzer, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58753-y · Cited by 11
“Beyond its role regulating metabolism via AMPK, LKB1 loss promotes tumorigenesis by reprogramming epigenetic states, facilitating lineage plasticity and promoting metastasis 22,67 – 70 .”
Shu, C., Li, J., Rui, J., Fan, D., Niu, Q., Bai, R., Cicka, D., Doyle, S. P., Wahafu, A., Zheng, X., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57297-5 · Cited by 13
“First, we found that WRJ388, a mouse tumor-derived cancer cell line isolated from our Kras G12D /Lkb1 -/- /p53 WT GEMM 36 , has downregulated STING expression as compared to KW634 cells 60 ( Kras G12D /Lkb1 WT /p53 -/- ) (Supplementary Fig.”
Precision immune regulation in KRAS-mutated cancers: the final piece of the puzzle?
Fu, S., Ma, J., Cai, C., Tan, J., Deng, X., Shen, H., Zeng, S., Chen, Y., & Han, Y. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03444-1 · Cited by 14
Okon, I. S., Coughlan, K. A., & Zou, M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.500934 · Cited by 11
Rousseau, B., Jacquot, C., PALABE, J. L., Malleter, M., Tomasoni, C., Boutard, T., Sakanyan, V. A., & Roussakis, C. (2015) · Scientific Reports · doi:10.1038/srep10356 · Cited by 13
Wang, Y., Wang, Z., Piha-Paul, S. A., Jankú, F., Subbiah, V., Shi, N., Hess, K. R., Broaddus, R. R., Shan, B., Naing, A., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25947 · Cited by 12
He, L., Wu, M.-Z., Wang, X., Qiu, X.-S., Wang, E., & Wu, G. (2019) · Journal of Cancer · doi:10.7150/jca.33237 · Cited by 11
“Functional deletion mutation of LKB1 gene is an important cause of tumorigenesis, and its inactivation is often observed in lung cancer [4], cervical cancer [5], breast cancer [6], and other tumors [3].”
BackgroundSelf-citationDey, S., Ashrafi, A., Vidal, C., Jain, N., Kalainayakan, S. P., Ghosh, P., Alemi, P. S., Salamat, N., Konduri, P. C., Kim, J., et al. (2022) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-21-0385 · Cited by 11
“They harbor a conditional activating mutation (G12D) at the endogenous Kras locus, a conditional Lkb1 knockout, and conditional luciferase expression formonitoring tumorigenesis in livemice (21, 22).”
BackgroundLKB1 is physiologically required for sleep from Drosophila melanogaster to the Mus musculus
Liu, Z., Jiang, L., Li, C., Li, C., Yang, J., Yu, J., Mao, R., & Rao, Y. (2022) · Genetics · doi:10.1093/genetics/iyac082 · Cited by 12
Xu, Y., Gu, L., Li, Y., Zhao, R., Hong, J., Xie, W., Liu, L., Wu, H., Ren, F., Han, Y., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1024818 · Cited by 12
Ross, F. A., Hawley, S. A., Russell, F. M., Goodman, N., & Hardie, D. G. (2023) · Biochemical Journal · doi:10.1042/bcj20230380 · Cited by 11
Restoring adiponectin via rosiglitazone ameliorates tissue wasting in mice with lung cancer
Langer, H. T., Ramsamooj, S., Dantas, E., Murthy, A., Ahmed, M., Ahmed, T., Hwang, S., Grover, R., Pozovskiy, R., Liang, R. J., et al. (2024) · Acta Physiologica · doi:10.1111/apha.14167 · Cited by 12
“KrasG12D/+;Lkb1f/f (KL) mice have been previously described [46].”
MethodLiver kinase B1 enhances chemoresistance to gemcitabine in breast cancer MDA-MB-231 cells
Chen, X., YE, F., Hu, X., Li, Z., Jiang, B., Fu, Y., Cheng, X., Shao, Z., & Zhuang, Z. (2014) · Oncology Letters · doi:10.3892/ol.2014.2446 · Cited by 11
“Somatic mutations in LKB1 have also been observed in sporadic pulmonary, breast, pancreatic and biliary cancers and melanomas (4-8).”
BackgroundIs 5´-AMP-Activated Protein Kinase Both Jekyll and Hyde in Bladder Cancer?
Kim, W. (2015) · International Neurourology Journal · doi:10.5213/inj.2015.19.2.55 · Cited by 13
Mack, H. I. D., & Münger, K. (2013) · Virology · doi:10.1016/j.virol.2013.07.009 · Cited by 12
REG4 is an indicator for KRAS mutant lung adenocarcinoma with TTF-1 low expression
Sun, S., Hu, Z., Huang, S., Ye, X., Wang, J., Chang, J., Wu, X., Wang, Q., Zhang, L., Hu, X., et al. (2019) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-019-02988-y · Cited by 12
Molecular Diagnostics in Non-Small Cell Lung Carcinoma
Sholl, L. M. (2020) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0039-3399564 · Cited by 13
Targeting Angiogenesis from Premalignancy to Metastases
Grandis, J. R., & Argiris, A. E. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0032 · Cited by 12
“Although inactivation of LKB1 has been shown to modulate metastatic potential in mouse models of lung cancer (18), its significance in human NSCLC metastasis is not fully understood.”
BackgroundShao, Y., Zhong, D., & Guan, S. (2020) · Translational Cancer Research · doi:10.21037/tcr.2019.11.34 · Cited by 11
“So even adenosquamous carcinoma could be the result of transformation from ADC to SCC (8).”
BackgroundRho, S. B., Byun, H. J., Kim, B.-R., & Lee, C. H. (2023) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2023.106 · Cited by 10
“…breast, ovarian, endometrial, pancreas, non-small cell lung, and thyroid carcinoma (Hemminki et al., 1998; Jenne et al., 1998; Zhong et al., 2006; Ji et al., 2007; Contreras et al., 2008; Shackelford and Shaw, 2009; Wingo et al., 2009; Shorning and Clarke, 2011; Zhao and Xu, 2014; Xu et al.,…”
BackgroundLiver kinase B1 suppresses growth of lung cancer cells through sonic hedgehog signaling pathway
Song, K., Zheng, G., & Zhao, Y. (2018) · Cell Biology International · doi:10.1002/cbin.10965 · Cited by 10
Wei, X. L., Liu, Q., Liu, L., Wang, D., Liu, J., Zhu, Q., Xu, Z., Chen, Q., & Xu, W. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147973 · Cited by 13
“Researchers have conducted extensive studies on the role of LKB1 in NSCLC, showing that LKB1 is involved in processes such as tumor differentiation, metastasis, immune response, and chemotherapy resistance [26,27].”
BackgroundInsights into targeting LKB1 in tumorigenesis
Trelford, C. B., & Shepherd, T. G. (2024) · Genes & Diseases · doi:10.1016/j.gendis.2024.101402 · Cited by 13
“111 In LKB1/KRAS mice, the adeno-to-squamous cell carcinoma transdifferentiation is mediated by the loss of lysyl oxidase, which up-regulates p63, an oncogene linked to squamous cell survival.”
C4.4A as a biomarker in pulmonary adenocarcinoma and squamous cell carcinoma
Jacobsen, B., Kriegbaum, M. C., Santoni-Rugiu, E., & Ploug, M. (2014) · World Journal of Clinical Oncology · doi:10.5306/wjco.v5.i4.621 · Cited by 10
Coordinated cell motility is regulated by a combination of LKB1 farnesylation and kinase activity
Wilkinson, S. C., Hou, Y., Zoine, J. T., Saltz, J. H., Zhang, C., Chen, Z., Cooper, L., & Marcus, A. I. (2017) · Scientific Reports · doi:10.1038/srep40929 · Cited by 10
“Recent in vivo and in vitro experiments show LKB1 loss also leads to adhesion defects, specifically FAK hyper-phosphorylation 5,8–10, 18, 27 .”
Mak, R. H., Hermann, G., Aerts, H. J. W. L., Baldini, E. H., Chen, A. B., Kozono, D., Rabin, M. S., Swanson, S., Chen, Y., Catalano, P. J., et al. (2018) · JCO Precision Oncology · doi:10.1200/po.17.00219 · Cited by 11
Self-citationHu, Y., Wu, M., Gu, N., Xu, H., Li, Q., & Wu, G. (2020) · Thoracic Cancer · doi:10.1111/1759-7714.13640 · Cited by 10
Self-citation[PI3K/Akt/mTOR signaling pathway and non-small cell lung cancer].
Qi, H., & Fan, L. (2010) · PubMed Central · doi:10.3779/j.issn.1009-3419.2010.12.13 · Cited by 10
Ren, Y., Zhao, F., Mo, H., Jia, R. R., Tang, J., Zhao, X. H., Wei, J. L., Huo, R. R., Li, Q. Q., & You, X. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-027185 · Cited by 10
“Articles were excluded if they (1) were duplicate publications; (2) were case reports, reviews, letters or animal studies or (3) did not report survival outcomes.”
BackgroundMethodColombo, M., Marabese, M., Vargiu, G., Broggini, M., & Caiola, E. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.532292 · Cited by 10
“LKB1 mutations were found in about 50% of KRAS-mutated NSCLC and it was demonstrated that the co-occurrence of LKB1/KRAS mutations significantly increases the tumor burden, mediated by increased resistance to classical anticancer and immunotherapeutic drugs thus corresponding with poor prognosis for patients carrying…”
BackgroundQian, J., Chen, R., Zhao, R., Han, Y., & Yu, Y. (2020) · Frontiers in Oncology · doi:10.2139/ssrn.3679866 · Cited by 13
E47 upregulates ΔNp63α to promote growth of squamous cell carcinoma
Xu, J., Li, F., Gao, Y., Guo, R., Ding, L., Fu, M., Yi, Y., Chen, H., Xiao, Z. J., & Niu, M. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03662-3 · Cited by 10
Keratin promoter based gene manipulation in the murine conducting airway
Malkoski, S. P., Cleaver, T. G., Lu, S., Lighthall, J. G., & Wang, X. (2010) · International Journal of Biological Sciences · doi:10.7150/ijbs.6.68 · Cited by 10
More than a Tumor Suppressor: E-Cadherin Loss Drives Lung Cancer Metastasis
Devlin, J. R., & Verschuren, E. W. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0063ed · Cited by 10
Wang, P., Zhang, S., Chen, X., Yang, X.-D., Huang, S., Yin, H., Duan, H.-Y., Zhou, F., Yu, J., Zhong, B., et al. (2025) · Protein & Cell · doi:10.1093/procel/pwaf101 · Cited by 18
Bhattacharya, D., Roman, B., & Reddy, S. (2026) · Cancer Gene Therapy · doi:10.1038/s41417-026-01003-0 · Cited by 11
“Concurrent KRAS/LKB1 mutations are associated with increased brain metastasis compared with other mutations, but LKB1 mutations alone are not associated with tumorigenesis [31].”
Vastrad, C. M., & Vastrad, B. M. (2019) · Gene Reports · doi:10.1016/j.genrep.2019.100394 · Cited by 12
Goss, G. D., Spaans, J. N., Huntsman, D. D., Asmis, T. R., Wright, N. A., Duciaume, M. M., Kaurah, P., Miller, R. R., Banerji, S. O., Sekhon, H. S., et al. (2022) · Current Oncology · doi:10.3390/curroncol29050258 · Cited by 9
“STK11 mutations, however, have not frequently been reported in SCC or other lung tumor subtypes [12,53].”
BackgroundThe Mutational Landscape of Cancer's Vulnerability to Ionizing Radiation
Gopal, P., Yard, B. D., Petty, A. P., Lal, J. C., Bera, T. K., Hoang, T. Q., Buhimschi, A. D., & Abazeed, M. E. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-1914 · Cited by 10
“STK11 is frequently inactivated in lung adenocarcinoma and leads to both increased primary tumor growth and the acquisition of metastatic potential (45, 46).”
BackgroundRab3B enhances the stabilization of DDX6 to promote lung adenocarcinoma aggressiveness
Yao, G., Yu, S., Hou, F., Xiao, Z., Li, G., Ji, X., & Wang, J. (2024) · Molecular Medicine · doi:10.1186/s10020-024-00848-1 · Cited by 9
AMPK signaling: A targetable tumor suppressor pathway?
Schneider, A., & Gartenhaus, R. B. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.11.13921 · Cited by 9
siRNA Suppression of NEDD9 Inhibits Proliferation and Enhances Apoptosis in Renal Cell Carcinoma
Wang, J., Yang, W., Sun, C., Luan, Y., Cheng, G., Li, K., & Kong, F. (2015) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504015x14386062091442 · Cited by 9
“Moreover, NEDD9 is overexpressed in various human cancers, including breast cancer, glioblastoma, melanoma, and lung cancers (9,14,15).”
Cheng, Z., Cheng, N., Shi, D., Ren, X., Gan, T., Bai, Y., & Yang, K. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16010120 · Cited by 9
“It can also activate the expression of p53 to decrease the transcription of LKB1, which is a critical barrier for pulmonary tumorigenesis, initiation control, differentiation and metastasis [61].”
BackgroundLong duration of immunotherapy in a STK11 mutated/KRAS wild-type non-small cell lung cancer patient
Domingues, I., Cedrés, S., Callejo, A., Vivancos, A. P., Martínez‐Martí, A., & Felip, E. (2020) · Pulmonology · doi:10.1016/j.pulmoe.2019.05.002 · Cited by 9
“STK11 is thought to have a role on pulmonary tumorigenesis, often associated with KRAS.3,4 The reported STK11 pS69* mutation results in a premature stop codon within its kinase domain, associated to more aggressive tumours, shorter progression-free survival and overall survival.1,3 Additionally, this mutation has been…”
BackgroundSystemic Ketone Replacement Does Not Improve Survival or Cancer Cachexia in Mice With Lung Cancer
Langer, H. T., Ramsamooj, S., Liang, R. J., Grover, R., Hwang, S., & Goncalves, M. D. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.903157 · Cited by 9
“Cachexia Model and Lung Tumor Induction Kras;Lkb1 mice have been previously described (11).”
BackgroundHuang, Y., Zhang, H., Feng, J., & Tang, B. (2022) · Apmis · doi:10.1111/apm.13271 · Cited by 11
“controls tumor genesis, differentiation, and metastasis [12].”
BackgroundGenetic Alterations of the LKB1 Gene in Head and Neck Cancer
Kenanli, E., Karaman, E., Enver, Ö., Ulutin, T., & Buyru, N. (2010) · DNA and Cell Biology · doi:10.1089/dna.2010.1060 · Cited by 9
“In addition, several somatic LKB1 alterations have been reported in a variety of carcinomas (Avizienyte et al. , 1998; Su et al. , 1999; Kim et al. , 2004; Ji et al. , 2007; Matsumoto et al. , 2007) except HNC.”
InfluentialMolecular mechanisms of LKB1 induced cell cycle arrest
Zhong, D., Sun, L., & Dong, L. (2012) · Thoracic Cancer · doi:10.1111/1759-7714.12003 · Cited by 11
Low LKB1 Expression Results in Unfavorable Prognosis in Prostate Cancer Patients
Lü, J., Sun, P., Sun, B., & Wang, C. (2015) · Medical Science Monitor · doi:10.12659/msm.894847 · Cited by 9
LKB1 expression reverses the tumorigenicity of L02 cells
Liang, X., Xu, G., Gao, Q., & Tao, X. (2016) · Oncology Reports · doi:10.3892/or.2016.4900 · Cited by 9
Outcomes of patients with stage III non-small cell lung cancer (NSCLC) that harbor a STK11 mutation
An, J., Yan, M., Yu, N., Chennamadhavuni, A., Furqan, M., Mott, S. L., Loeffler, B. T., Kruser, T. J., Sita, T. L., Feldman, L. E., et al. (2021) · Translational Lung Cancer Research · doi:10.21037/tlcr-21-177 · Cited by 10
“More importantly, in-vivo studies indicate that STK11 is involved in the differentiation and metastases of lung cancer (6).”
BackgroundSHP-2 inhibits tyrosine phosphorylation of Cas-L and regulates cell migration
Yo, K., Iwata, S., Hashizume, Y., Kondo, S., Nomura, S., Hosono, O., Kawasaki, H., Tanaka, H., Dang, N. H., & Morimoto, C. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.03.010 · Cited by 11
“Furthermore, recent publications have reported novel findings on the role of Cas-L in tumor progression [3,7].”
BackgroundPro-tumorigenic AMPK in glioblastoma
Leli, N. M., & Koumenis, C. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0129-9 · Cited by 9
Scicchitano, S., Garofalo, C., Stella, B., Santamaria, G., Cozzolino, F., Monaco, V., Biamonte, F., Monti, M., Vecchio, E., & Faniello, M. C. (2025) · FEBS Journal · doi:10.1111/febs.70191 · Cited by 8
STK11Inactivation Predicts Rapid Recurrence in Inoperable Early-Stage Non–Small-Cell Lung Cancer
Katipally, R. R., Spurr, L. F., Gutiontov, S. I., Turchan, W. T., Connell, P. P., Juloori, A., Malik, R., Binkley, M. S., Jiang, A. L., Rouhani, S. J., et al. (2023) · JCO Precision Oncology · doi:10.1200/po.22.00273 · Cited by 9
“58 We hypothesize that STK11 mutations por-tend early metastatic dissemination and distant relapse.”
Lagoudaki, E. D., Koutsopoulos, A. V., Sfakianaki, M., Papadaki, C., Manikis, G. C., Voutsina, A., Trypaki, M., Tsakalaki, E., Fiolitaki, G., Hatzidaki, D., et al. (2024) · Cancers · doi:10.3390/cancers16101818 · Cited by 9
“Furthermore, LKB1-deficient tumors yielded increased expression of genes involved in angiogenesis and cell migration, such as NEDD9 and CD24 [32].”
BackgroundTGM1/3-mediated transamidation of Exo70 promotes tumor metastasis upon LKB1 inactivation
Hou, J., Mei, K., Wang, D., Ke, S., Chen, X., Shang, J., Li, G., Gao, Y., Xiong, H., Zhang, H., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114604 · Cited by 10
Self-citationWang, X., Jin, Y., Xu, L., Tao, S., Wu, Y., & Ao, C. (2024) · Cancer Control · doi:10.1177/10732748241274228 · Cited by 9
“NEDD9 is a focal adhesion scaffolding protein and is associated with tumor invasion and metastasis , 62-65 while it is rarely reported in cervical cancer.”
Khan, M. B., Huang, X., Ye, X., Zhang, D., Wang, B., Xu, A., Li, R., Ren, A., Chen, C., Song, J., et al. (2024) · Annals of Medicine · doi:10.1080/07853890.2024.2405079 · Cited by 9
Levi, A., Blais, E. M., Davelaar, J., Ebia, M., Minasyan, A., Nikravesh, N., Gresham, G. K., Zheng, L., Chuy, J. W., Shroff, R. T., et al. (2025) · The Oncologist · doi:10.1093/oncolo/oyaf007 · Cited by 10
“34,35 However, the other two genetic alterations enriched in lung-only mPDAC do not unquestionably bestow an aggressive tumor characteristic; a finding that differs from that of liver-only mPDAC.”
Genetically Engineered Mouse Models for Human Lung Cancer
Inoue, K., Fry, E. A., Maglic, D., & Zhu, S. (2013) · InTech eBooks · doi:10.5772/53721 · Cited by 9
“Moreover, reconstitution of LKB1 in human NSCLC cell lines showed anti-tumor effects independent of their p53 or INK4A/ARF status (Ji et al., 2007).”
BackgroundMethodInfluentialDueñas, M., Santos, M., Aranda, J. F., Bielza, C., Martínez‐Cruz, A. B., Lorz, C., Tarón, M., Ciruelos, E., Rodríguez‐Peralto, J. L., Martín, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042494 · Cited by 10
“Raw GE data were downloaded from the GEO database (Table S1) [10,11,16–22] and similarities with the 682-gene tumour signature sought by calculating Pearson correlations (see Materials and Methods).”
MethodPinto, A. T., Pojo, M., Simões‐Pereira, J., Roque, R. R., Saramago, A., Roque, L., Martins, C., André, S., Cabeçadas, J., Leite, V. A. P. H., et al. (2019) · Endocrine · doi:10.1007/s12020-019-02009-5 · Cited by 8
Xiao, Z., Shi, G., Xi, S., Singh, A. K., Willette‐Brown, J., Li, X., Zhu, F., Su, L., Wu, X., Schrump, D. S., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05308-4 · Cited by 9
“Furthermore, Ikka-deficient lung ADCs contribute to a protumor immunosuppressive milieu by upregulating TNF expression, which activates TNFR2/NF-κB/Foxp3 signaling to enhance the conversion of CD4 T cells to Foxp3 Treg cells in KrasD12GIkkaΔLU mice that have a wild-type immunological background before Ras activation a…”
BackgroundInfluentialShi, S., Li, J., Zhang, Z., Tu, H., & Max, C. (2023) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2023.116661 · Cited by 8
Increased LOXL2 expression is related to poor prognosis in lung squamous cell carcinoma
Cao, L., Zhong, J., Liu, Z., Jiang, J., Zhu, C., Liu, F., & Wang, B. (2024) · Journal of Thoracic Disease · doi:10.21037/jtd-23-1848 · Cited by 8
Emerging Role of MicroRNAs and Long Noncoding RNAs in Healthy and Diseased Lung
Xiao, J., Hao, Q., Wang, K., Paul, J. P., & Wang, Y.-X. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-63245-2_22 · Cited by 8
Tayou, J. (2018) · Cellular Oncology · doi:10.1007/s13402-018-0377-5 · Cited by 8
Loss of hypermethylated in cancer 1 (HIC1) promotes lung cancer progression
Li, Y., Yao, M., Wu, T., Zhang, L., Wang, Y., Chen, L., Fu, G., Weng, X., & Wang, J. (2018) · Cellular Signalling · doi:10.1016/j.cellsig.2018.10.006 · Cited by 8
Self-citationOxalomalate suppresses metastatic melanoma through IDH-targeted stress response to ROS
Kim, S. H., Kim, H. J., Lee, J. H., & Park, J. (2019) · Free Radical Research · doi:10.1080/10715762.2019.1597974 · Cited by 8
“This, in turn, increases transcription of genes involved in metastasis, such as COX-2 and MMP9 [48,49].”
BackgroundDUSP22 inhibits lung tumorigenesis by suppression of EGFR/c-Met signaling
Lin, H.-H., Chang, C., Liao, Y., Yeh, S., Lin, H.-P. P., Ho, H., Cheung, C. H. Y., Juan, H., Chen, Y., Su, Y., et al. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02038-8 · Cited by 10
“Abnormal expression of certain DUSPs has been observed in various cancers [20 – 22].”
Self-citationPeng, J., Lu, Z., Sai, F., Liang, M., Zhang, X., Ru, D., Song, Y., Wei, X., Gao, L., & Wang, H.-Q. (2025) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x25500429 · Cited by 7
Self-citationBharadwaj, S., Mierzwicka, J. M., Vaňková, L., & Malý, P. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02410-w · Cited by 9
If Virchow and Ehrlich Had Dreamt Together: What the Future Holds for KRAS-Mutant Lung Cancer
Köhler, J., & Janne, P. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063025 · Cited by 7
STK11 genetic alterations in metastatic EGFR mutant lung cancer
Yin, D., Lu, X., Xiao, L., Lu, Y., Xiong, L., Wu, P., Wang, T., & Chen, J. (2025) · Scientific Reports · doi:10.1038/s41598-024-74779-6 · Cited by 8
“STK11 genetic alterations occur in 15–30% of lung adenocarcinomas (LUAD), frequently manifesting as deletions or point mutations 9,13 .”
Lkb1 Downregulation Links PVAT Remodeling to Aortic Dilation or Aneurysm
Cai, Z., Liang, M., Jiang, Y., Chen, H., Hu, Y., Huang, Y., Huo, H., Shen, L., & He, B. (2025) · Circulation Research · doi:10.1161/circresaha.125.326297 · Cited by 8
Self-citationWang, Z., Feng, Y., Bardessy, N., Wong, K., Liu, X., & Ji, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037308 · Cited by 8
“Purification of gDNA in cells and mice tissues were previously described [29].”
MethodSelf-citationChoi, S. H., Do, S. K., Lee, S. Y., Choi, J. E., Kang, H., Hong, M. J., Lee, J. H., Lee, W. K., Jeong, J. Y., Shin, K. M., et al. (2022) · Thoracic Cancer · doi:10.1111/1759-7714.14688 · Cited by 8
Adenylosuccinate synthetase 1 gene is a novel target of deletion in lung adenocarcinoma
Miller, J. C., Blake, D. C., & Herzog, C. R. (2009) · Molecular Carcinogenesis · doi:10.1002/mc.20563 · Cited by 7
“The latter is frequently inactivated in sporadic human LAC [41,42].”
BackgroundLKB1 as a Tumor Suppressor in Uterine Cancer: Mouse Models and Translational Studies
Peña, C. G., & Castrillón, D. H. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-43139-0_7 · Cited by 7
Sha, L., Lian, F., Li, K., Chen, C., Zhao, Y., He, J., HUANG, S. H., & Wu, G. (2018) · Europe PMC (PubMed Central) · Cited by 9
Talwelkar, S. S., Nagaraj, A. S., Devlin, J. R., Hemmes, A., Potdar, S., Kiss, E. A., Saharinen, P., Salmenkivi, K., Mäyränpää, M. I., Wennerberg, K., et al. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-0573 · Cited by 7
“The KP and KL GEMMs also demonstrate differences in tumor latency and metastatic propensity, as well as therapeutic sensitivity (9, 10).”
BackgroundInfluentialInhibition of β-Catenin Activity Abolishes LKB1 Loss-Driven Pancreatic Cystadenoma in Mice
Hsieh, M.-J., Weng, C., Lin, Y., Wu, C., Chen, L., & Cheng, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094649 · Cited by 7
Self-citationDeciphering the critical roles of the AMPK/mTOR signaling pathway in cancer cell metabolism (Review)
Alasadi, A., Fadhil, N. M., & Chen, S. (2025) · World Academy of Sciences Journal · doi:10.3892/wasj.2025.391 · Cited by 10
Lin, Z., Ashish, S., Huang, L., Li, S., Li, Y., Zhou, Y., & Gu, J. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1676797 · Cited by 7
“STK11 , also known as LKB1 (Liver kinase B1), whose loss-function mutation occurs in approximately 10% of NSCLC, is a tumor suppressor gene that plays a critical role in cellular processes such as metabolic reprogramming, cell polarity, and proliferation (14 – 17).”
IL-17 links the tumor suppressor LKB1 to gastrointestinal inflammation and polyposis
Compton, S. E., DeCamp, L. M., Oswald, B. M., Kitchen-Goosen, S. M., Lau, K. H., Fillinger, R. J., Dahabieh, M. S., Ark, A. V., Krawczyk, C. M., & Jones, R. G. (2025) · Science Advances · doi:10.1126/sciadv.adt5933 · Cited by 7
CD49b inhibits osteogenic differentiation and plays an important role in osteosarcoma progression
Ren, T., Piperdi, S., Koirala, P., Park, A., Zhang, W., Ivenitsky, D., Zhang, Y., Villanueva‐Siles, E., Hawkins, D. S., Roth, M. E., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.21254 · Cited by 6
“Inactivation of LKB1 in non-small cell lung cancer leads to altered cell differentiation and increased ability to metastasize [25].”
The level of oncogenic Ras determines the malignant transformation of Lkb1 mutant tissue in vivo
Rackley, B. B., Seong, C.-S., Kiely, E. J., Parker, R. E., Rupji, M., Dwivedi, B., Heddleston, J. M., Giang, W., Anthony, N. R., Chew, T., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-01663-8 · Cited by 6
ZHANG, Y., YANG, W., HAN, X., QIAO, Y., WANG, H., Chen, T., LI, T., & Ou, W. (2024) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2024.045025 · Cited by 6
Bu, W., & Li, Y. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-70875-6_8 · Cited by 6
Ding, S. L., Zhou, R., & Zhu, Y. (2015) · Acta Crystallographica Section F Structural Biology Communications · doi:10.1107/s2053230x15012595 · Cited by 6
“LKB1 functions as a tumour suppressor by regulating cell polarity, advancing cell differentiation and controlling cell division and energy metabolism (Ji et al., 2007; Makowski & Hayes, 2008; Alessi et al., 2006).”
BackgroundGhahhari, N. M., Ghahhari, H. M., & Kadivar, M. (2012) · Oncology Research and Treatment · doi:10.1159/000345131 · Cited by 6
Metadata
- Authors
- Ji, H., Ramsey, M. R., Hayes, D. N., Fan, C., McNamara, K., Kozlowski, P., Torrice, C., Wu, M. C., Shimamura, T., Perera, S. A., Liang, M.-C., Cai, D., Naumov, G. N., Bao, L., Contreras, C. M., Li, D., Chen, L., Krishnamurthy, J., Koivunen, J., Chirieac, L. R., Padera, R. F., Bronson, R. T., Lindeman, N. I., Christiani, D. C., Lin, X., Shapiro, G. I., Jänne, P. A., Johnson, B. E., Meyerson, M., Kwiatkowski, D. J., Castrillon, D. H., Bardeesy, N., Sharpless, N. E., & Wong, K.-K.
- Affiliations
- Dana-Farber Cancer Institute (US)
- University of North Carolina at Chapel Hill (US)
- Harvard University (US)
- University of Tennessee Health Science Center (US)
- Harold C. Simmons Comprehensive Cancer Center (US)
- Brigham and Women's Hospital (US)
- Broad Institute (US)
- Massachusetts General Hospital (US)
- Corresponding author
- Bardeesy, Nabeel
- Sharpless, Norman E.
- Wong, Kwok-Kin
- ORCID
- Ji, Hongbin
- Ramsey, Matthew R.
- Hayes, D. Neil
- Wu, Michael C.
- Shimamura, Takeshi
- Perera, Samanthi A.
- Liang, Mei-Chih
- Bao, Lei
- Chen, Liang
- Koivunen, Jussi
- Chirieac, Lucian R.
- Padera, Robert F.
- Bronson, Roderick T.
- Lindeman, Neal I.
- Christiani, David C.
- Lin, Xihong
- Shapiro, Geoffrey I.
- Johnson, Bruce E.
- Meyerson, Matthew
- Kwiatkowski, David J.
- Bardeesy, Nabeel
- Sharpless, Norman E.
- Wong, Kwok-Kin
- Venue
- Nature
- Published
- 2007-08-05
- Volume
- 448
- Issue
- 7155
- Pages
- 807-810
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2134964552
- Cited by
- 1,064
- References
- 36
- Citations by year
- 2026: 30 · 2025: 43 · 2024: 44 · 2023: 66 · 2022: 50 · 2021: 71 · 2020: 51 · 2019: 66 · 2018: 61 · 2017: 56 · 2016: 54 · 2015: 72 · 2014: 83 · 2013: 65 · 2012: 52
- FWCI
- 24.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- The Mouseion at the JAXlibrary (Jackson Laboratory) (submittedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Lung Cancer Research Studies
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Treatments and Mutations
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- LKB1, STK11, lung cancer, tumour suppressor, metastasis, squamous cell carcinoma, non-small cell lung cancer, KRAS, p53, Ink4a/Arf, CDKN2A, tumor differentiation, Peutz-Jeghers syndrome, metastasis-promoting genes
- MeSH terms
- AMP-Activated Protein Kinase Kinases, Animals, Carcinoma, Non-Small-Cell Lung, Cell Differentiation, Disease Models, Animal, Humans, Lung Neoplasms, Neoplasm Metastasis, Genes, ras, Gene Expression Regulation, Neoplastic, Genes, Tumor Suppressor, Genes, p53, Protein Serine-Threonine Kinases, Genes, p16, Gene Expression Profiling, Cell Line, Tumor, Mice, Genes, Neoplasm, AMP-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.